Suraksha Diagnostic share price target 2027 is Rs 260 (-1%), 2028 is Rs 300 (+15%), and 2030 is Rs 395 (+51%). Diversified stock long term analyst forecast.

Bodhi Tree Multiversal Q1 FY27 results showed consolidated revenue surging 65% to Rs 30 crore while PAT fell 27% to Rs 78 lakh as gross profit held flat at Rs 1 crore on significant content investment.

DCM Q1 FY27 results showed consolidated revenue growing 15% to Rs 20 crore while PAT surged approximately 2000% to Rs 42 lakh from near-zero in Q1 FY26, driven by operating leverage above breakeven.

IP Rings Q1 FY27 results showed consolidated revenue growing 18% to Rs 96 crore and PAT surging 230% to Rs 1 crore from Rs 0.46 crore in Q1 FY26, driven by auto sector growth and operating leverage.

Mangalam Seeds Q1 FY27 results showed consolidated revenue growing 26% to Rs 61 crore while PAT held flat at Rs 3 crore with just 1.93% growth as gross profit remained at Rs 5 crore on procurement cost inflation.

AVI Polymers Q1 FY27 results showed consolidated revenue at Rs 66 crore and PAT at Rs 4 crore with gross profit Rs 5 crore, marking the company’s transition to meaningful commercial polymer manufacturing operations.

Brady and Morri Q1 FY27 results showed standalone revenue declining 12% to Rs 17 crore and PAT nearly halving to Rs 77 lakh from Rs 1 crore in Q1 FY26 as gross profit contracted.

Achyut Health Q1 FY27 results showed standalone revenue flat at Rs 3 crore while PAT grew 28% to Rs 14 lakh as gross profit more than doubled to Rs 0.15 crore from Rs 0.07 crore in Q1 FY26.